Related Experiment Video

Updated: Aug 9, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Translational regulation of p53 as a potential tumor therapy target

Björn Schumacher1, Anton Gartner

  • 1Department of Genetics, Erasmus MC, Dr. Molewaterplein 50, 3015GE Rotterdam, The Netherlands. b.schumacher@erasmusmc.nl

Future Oncology (London, England)
|March 25, 2006
PubMed

Insights

The tumor suppressor p53 induces apoptosis. Researchers used C. elegans to find new ways to regulate p53, potentially leading to novel cancer therapies targeting p53 regulators.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • The tumor suppressor p53 is crucial for apoptosis induction, responding to DNA damage and oncogenic stress.
  • Activating p53 is a key cancer therapy strategy, making the inhibition of its negative regulators equally important.
  • Caenorhabditis elegans serves as a model organism for studying conserved biological pathways, including apoptosis.

Purpose of the Study:

  • To explore the potential of C. elegans genetics in identifying novel regulators of p53-mediated apoptosis.
  • To discuss the utility of the C. elegans system for screening apoptosis-inducing cancer drugs.
  • To uncover therapeutic targets for human cancer by studying conserved p53 regulatory mechanisms.

Main Methods:

  • Utilizing C. elegans genetics to investigate p53 homolog cep-1/p53 regulatory mechanisms.
  • Analyzing the conserved pathway of p53-mediated apoptosis from worms to humans.
  • Reviewing a novel regulatory mechanism involving germ line defective-1-mediated translational repression of cep-1/p53.

Main Results:

  • The C. elegans p53 homolog, cep-1/p53, mediates apoptosis upon DNA damage through a conserved pathway.
  • A novel mechanism of cep-1/p53 regulation by germ line defective-1-mediated translational repression has been identified.
  • The study highlights the potential of C. elegans for discovering new cancer drug targets.

Conclusions:

  • The C. elegans system offers a powerful platform for identifying novel p53 regulators and potential cancer therapeutics.
  • Understanding conserved p53 regulatory mechanisms in C. elegans can lead to the development of targeted cancer therapies.
  • Inhibition of negative p53 regulators identified in C. elegans may represent a promising strategy for cancer treatment.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...